心理药物:皮肤病学使用的实用指南
E Carmona-Rocha1, J De Diego-Adeliño2, M J Tribó3
1Servicio de Dermatología y Venereología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Institut de Recerca Sant Pau (IR Sant Pau), Spain; Universitat Autònoma de Barcelona (UAB), Spain.
Actas dermo-sifiliograficas
|December 6, 2025
概括
本综述指导皮肤科医生使用心理药物治疗皮肤和精神疾病患者. 它为皮肤病学实践中管理精神病相关疾病提供了实际建议.
科学领域:
- 心理皮肤学 心理皮肤学
- 临床皮肤病学临床皮肤病学
- 心理药理学 心理药理学
背景情况:
- 在皮肤病患者中,精神病发病率高.
- 精神疾病可以表现为皮肤症状.
- 皮肤病严重影响心理健康.
研究的目的:
- 为皮肤病学中心理药物使用提供实用指南.
- 为了解决心理健康和皮肤病学的交叉点.
- 为皮肤科医生提供整体患者管理工具.
主要方法:
- 心理药物应用的叙事审查.
- 专注于常用的精神药物药物.
- 综合有关适用情况,剂量和不良影响的信息.
主要成果:
- 皮肤病学中精神药物指示的全面概述.
- 关于剂量和不良反应的详细信息.
- 特别人群的考虑和禁忌.
结论:
- 心理药物对于管理患有精神皮肤病症的患者至关重要.
- 皮肤科医生需要关于心理药物选择和管理的指导.
- 综合护理改善了皮肤病和心理健康交叉的患者的治疗结果.
相关概念视频
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Psychosis: Goals of Pharmacotherapy
446
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
446
Psychosis and Antipsychotic Drugs: Overview
779
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
779
Antipsychotic Drugs: Therapeutic Uses and Side Effects
712
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
712
Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182


